52 research outputs found
NiO-Nanofillers Embedded in Graphite/PVA-Polymer Matrix for efficient Electromagnetic Radiation Shielding
In this study, we report on the preparation of NiO/graphite sheets nanofillers in PVA-polymer matrix using a simple cost-effective hydrothermal process for EM shielding effectiveness applications. The careful optimization of the growth conditions and NiO/G/PVA relative ratios have resulted in NiO nanoparticles formation with homogeneous density. In this nanocomposite, the NiO nanoparticles and graphite sheets were incorporated into a polymer to enhance the electromagnetic shielding effectiveness. The morphological, structural, and chemical analysis have been conducted by SEM, EDX and XRD techniques. EDX and XRD analysis confirmed the exact chemical composition with high purity. SEM images showed the best morphology with homogenous NiO-nanoparticles distribution on graphite sheets for 15 wt% NiO relative ratio NiO/G/PVA nanocomposite. The nanocomposite was tested in different environments and shielding chambers that contained relatively high-level exposure to electromagnetic radiation. The shielding effectiveness (SE) measurements of NiO/G/PVA showed a significant increase of shielding effectiveness of about 17 dB compared to the commercial shielding paint. This can be ascribed to the homogenous distribution of NiO-NPs over the entire graphite sheets and the strong interaction of the incident electromagnetic radiation with the magnetic and electric dipoles in the nanocomposite. These finding is promising for enhanced flexible and cost-effective EMI shielding applications
PathogenMip Assay: A Multiplex Pathogen Detection Assay
The Molecular Inversion Probe (MIP) assay has been previously applied to a large-scale human SNP detection. Here we describe the PathogenMip Assay, a complete protocol for probe production and applied approaches to pathogen detection. We have demonstrated the utility of this assay with an initial set of 24 probes targeting the most clinically relevant HPV genotypes associated with cervical cancer progression. Probe construction was based on a novel, cost-effective, ligase-based protocol. The assay was validated by performing pyrosequencing and Microarray chip detection in parallel experiments. HPV plasmids were used to validate sensitivity and selectivity of the assay. In addition, 20 genomic DNA extracts from primary tumors were genotyped with the PathogenMip Assay results and were in 100% agreement with conventional sequencing using an L1-based HPV genotyping protocol. The PathogenMip Assay is a widely accessible protocol for producing and using highly discriminating probes, with experimentally validated results in pathogen genotyping, which could potentially be applied to the detection and characterization of any microbe
Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Recent genome-wide association studies of Alzheimer's disease (AD) have identified variants in BIN1, CLU, CR1 and PICALM that show replicable association with risk for disease. We have thoroughly sampled common variation in these genes, genotyping 355 variants in over 600 individuals for whom measurements of two AD biomarkers, cerebrospinal fluid (CSF) 42 amino acid amyloid beta fragments (Aβ42) and tau phosphorylated at threonine 181 (ptau181), have been obtained. Association analyses were performed to determine whether variants in BIN1, CLU, CR1 or PICALM are associated with changes in the CSF levels of these biomarkers. Despite adequate power to detect effects as small as a 1.05 fold difference, we have failed to detect evidence for association between SNPs in these genes and CSF Aβ42 or ptau181 levels in our sample. Our results suggest that these variants do not affect risk via a mechanism that results in a strong additive effect on CSF levels of Aβ42 or ptau181
Radiations and male fertility
During recent years, an increasing percentage of male infertility has to be attributed to an array of environmental,
health and lifestyle factors. Male infertility is likely to be affected by the intense exposure to heat and extreme
exposure to pesticides, radiations, radioactivity and other hazardous substances. We are surrounded by several types
of ionizing and non-ionizing radiations and both have recognized causative effects on spermatogenesis. Since it is
impossible to cover all types of radiation sources and their biological effects under a single title, this review is
focusing on radiation deriving from cell phones, laptops, Wi-Fi and microwave ovens, as these are the most
common sources of non-ionizing radiations, which may contribute to the cause of infertility by exploring the effect
of exposure to radiofrequency radiations on the male fertility pattern. From currently available studies it is clear that
radiofrequency electromagnetic fields (RF-EMF) have deleterious effects on sperm parameters (like sperm count,
morphology, motility), affects the role of kinases in cellular metabolism and the endocrine system, and produces
genotoxicity, genomic instability and oxidative stress. This is followed with protective measures for these radiations
and future recommendations. The study concludes that the RF-EMF may induce oxidative stress with an increased
level of reactive oxygen species, which may lead to infertility. This has been concluded based on available
evidences from in vitro and in vivo studies suggesting that RF-EMF exposure negatively affects sperm quality
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Background:
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke.
Methods:
We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515.
Findings:
Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group.
Interpretation:
In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes.
Funding:
GlaxoSmithKline
Reducing Working Expenses of Heat Exchangers of Refrigeration Installation Obtained by Method of Heat-Saving Analysis
Artificial semi-rigid tissue sensitized with natural pigments: Effect of photon radiations
Background: A new approach for evaluating the optical penetration depth and testing its validity with Monte Carlo simulations and Kubelka-Munk theory is used for artificial semi-rigid tissue sensitized with natural pigments. Photodynamic therapy is a promising cancer treatment in which a photosensitizing drug concentrates in malignant cells and is activated by visible light at certain wavelength. Materials and Methods: Cheap artificial semi-rigid tissue incorporated with scattering and absorbing materials along with some other composites comparable to normal human tissue has been performed. The optical parameters as measured with different conditions and calculated with various techniques are investigated. Results: The probability of interaction of light with tissue is very high when exposed to light in presence of Cichorium pumilum and RBCs followed by photohemolysis or/and photodegradation. The optical penetration depth calculated by linear absorption coefficient ranges from 0.63 to 2.85 mm is found to be comparable to those calculated using Kubelka-Munk theory or Monte Carlo simulation (range from 0.78 to 2.42 mm). The ratio of absorption to the scattering is independent of thickness and decreases with increasing irradiation time. Moreover, the optical parameters as well as their ratios are in very good agreement in the two approaches of calculation. The values of absorption and scattering coefficients are independent of thickness. Furthermore, the average photon ranges in the samples containing no scattering and absorbing materials are about three times greater than those samples containing scattering materials. Conclusion: Our results suggest that light propagation with optical properties presented in this work could be applicable in diagnostic and therapeutic of the human biological tissue for photodynamic therapy
Dielectric relaxation, XPS and structural studies of polyethylene oxide/iodine complex composite films
Polyethylene oxide (PEO) complexed with molecular iodine (I2) forming PEO/I2 complex composites stand‐free films were investigated using dielectric relaxation, X-ray photoelectron spectroscopy (XPS), UV–Vis spectrophotometry, structural and morphological techniques. Scanning electron microscopy was used to monitor the variation in the surface morphology and the related roughness. 2D Energy-dispersive X-ray spectroscopy (EDX) measurements enabled to observe the distribution of iodine on the film surface. High resolution XPS measurements were used to define the iodine anion types and the metallic iodine existence, as well as the relevant concentrations based on the binding energies. The dielectric relaxation measurements were carried out over the frequency range from 0.1 to 107 Hz and temperature range from 155 to 330 K. Dielectric loss (ε′′) curves were fitted to the Havriliak–Negami (HN) model for one and/or two relaxation peaks (α and β), with and without the electrical conductivity contribution term, in order to deduce the relaxation time (τ) and the dielectric strengths (Δε), in addition to the electrical conductivities (σ). The temperature-dependent data of β- and σ- relaxations follow the law of Arrhenius thermal activation indicating the presence of typical glass-forming polymers. Δε of α-relaxation obeys the curvature pattern of Vogel-Tammann-Fulcher (VTF) thermal activation law. The electrical conductivity of the system increases 6000 folds by doping PEO with 5 wt% of iodine at the same temperature (293 K).Jordan University of Science and Technology; this
research was supported by the Deanship of Scientifc Research under Grant Number: 420/2019. The
authors extend thanks to the Lehrstuhl Experimentelle Physik III, Technische Universität Dortmund, Germany for ofering the measurements via the broadband impedance spectroscopy and the full technical and
experimental suppor
- …